NCT02278471
The SCCS Polypill Pilot Trial
See it on ClinicalTrials.gov ↗303 people
54.1%
45.9%
164 womenmiddle line = equal numbers139 men
- Phase
- PHASE2
- Paid for by
- Vanderbilt University
- Finished
- 2018-06-27
- Health conditions
- Hypertension, Hyperlipidemia
- Who could join
- Anyone
- Ages
- 45 Years – 75 Years
- Average age
- median 56 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Black / African American 96.4% · White 3.6% · American Indian / Alaska Native 0% · Asian 0% · Native Hawaiian / Pacific Islander 0% · More than one race 0% · Not reported 0%
Women left out
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“History of liver disease, not including chronic, clinically-stable hepatitis”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“History of coronary heart disease or stroke”
- No diabetes
Women with diabetes were turned away.
“Insulin-dependent diabetes”
- No cancer
Women with current or past cancer were turned away.
“History of cancer, except for basal cell skin cancer”
Study titles and rules are shown in their original English.